Upgrade to SI Premium - Free Trial

Bank of America cuts Pfizer (PFE) on post-Covid uncertainties, upgrades Merck (MRK)

January 4, 2023 9:10 AM
Bank of America analyst Geoff Meacham downgraded Pfizer (NYSE: PFE) stock to Neutral from Buy, citing long-term uncertainty. The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades Hot Downgrades Hot List Hot Upgrades Upgrades

Next Articles